Works matching DE "PROTEIN-tyrosine kinases"
Results: 5000
Use of Erlotinib or Gefitinib as Initial Therapy in Advanced NSCL.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 5, p. 392
- By:
- Publication type:
- Article
Building on the Foundation of 5-FU to Treat Metastatic Colorectal Cancer.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 4, p. 462
- By:
- Publication type:
- Article
When Imatinib Fails.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 4, p. 448
- By:
- Publication type:
- Article
Second-Generation TKIs in Chronic Myelogenous Leukemia.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 4, p. 446
- By:
- Publication type:
- Article
Refractory CML: Not All Forms of Resistance Are Equal.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 4, p. 437
- By:
- Publication type:
- Article
Management of Patients With Resistant or Refractory Chronic Myelogenous Leukemia.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 4, p. 430
- By:
- Publication type:
- Article
Is Guillain Barré Syndrome Likely in This Patient?
- Published in:
- Oncology (08909091), 2008, v. 22, n. 1, p. 70
- By:
- Publication type:
- Article
Guillain-Barré Syndrome After Treatment With Sunitinib Malate?
- Published in:
- Oncology (08909091), 2008, v. 22, n. 1, p. 66
- By:
- Publication type:
- Article
Drug Essentials.
- Published in:
- Oncology (08909091), 2007, v. 21, p. 48
- By:
- Publication type:
- Article
The Saba/Khuri/Shin Article Reviewed.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 2, p. 172
- By:
- Publication type:
- Article
Targeting the Epidermal Growth Factor Receptor.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 2, p. 153
- By:
- Publication type:
- Article
Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase.
- Published in:
- Nature Structural & Molecular Biology, 2014, v. 21, n. 7, p. 579, doi. 10.1038/nsmb.2849
- By:
- Publication type:
- Article
Structural basis of recognition of interferon-α receptor by tyrosine kinase 2.
- Published in:
- Nature Structural & Molecular Biology, 2014, v. 21, n. 5, p. 443, doi. 10.1038/nsmb.2807
- By:
- Publication type:
- Article
Structurally encoded intraclass differences in EphA clusters drive distinct cell responses.
- Published in:
- Nature Structural & Molecular Biology, 2013, v. 20, n. 8, p. 958, doi. 10.1038/nsmb.2617
- By:
- Publication type:
- Article
Interaction with Shc prevents aberrant Erk activation in the absence of extracellular stimuli.
- Published in:
- Nature Structural & Molecular Biology, 2013, v. 20, n. 5, p. 620, doi. 10.1038/nsmb.2557
- By:
- Publication type:
- Article
Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F.
- Published in:
- Nature Structural & Molecular Biology, 2012, v. 19, n. 8, p. 754, doi. 10.1038/nsmb.2348
- By:
- Publication type:
- Article
Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl.
- Published in:
- Nature Structural & Molecular Biology, 2012, v. 19, n. 2, p. 184, doi. 10.1038/nsmb.2231
- By:
- Publication type:
- Article
Mechanistic insights into the activation of oncogenic forms of EGF receptor.
- Published in:
- Nature Structural & Molecular Biology, 2011, v. 18, n. 12, p. 1388, doi. 10.1038/nsmb.2168
- By:
- Publication type:
- Article
The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling.
- Published in:
- Nature Structural & Molecular Biology, 2011, v. 18, n. 9, p. 971, doi. 10.1038/nsmb.2099
- By:
- Publication type:
- Article
Alternative splicing of SYK regulates mitosis and cell survival.
- Published in:
- Nature Structural & Molecular Biology, 2011, v. 18, n. 6, p. 673, doi. 10.1038/nsmb.2040
- By:
- Publication type:
- Article
An extracellular steric seeding mechanism for Eph-ephrin signaling platform assembly.
- Published in:
- Nature Structural & Molecular Biology, 2010, v. 17, n. 4, p. 398, doi. 10.1038/nsmb.1782
- By:
- Publication type:
- Article
A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain.
- Published in:
- Nature Structural & Molecular Biology, 2010, v. 17, n. 4, p. 519, doi. 10.1038/nsmb.1793
- By:
- Publication type:
- Article
Activation of tyrosine kinases by mutation of the gatekeeper threonine.
- Published in:
- Nature Structural & Molecular Biology, 2008, v. 15, n. 10, p. 1109, doi. 10.1038/nsmb.1486
- By:
- Publication type:
- Article
Structural and biochemical characterization of the KRLB region in insulin receptor substrate-2.
- Published in:
- Nature Structural & Molecular Biology, 2008, v. 15, n. 3, p. 251, doi. 10.1038/nsmb.1388
- By:
- Publication type:
- Article
Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK.
- Published in:
- Nature Structural & Molecular Biology, 2007, v. 14, n. 6, p. 503, doi. 10.1038/nsmb1241
- By:
- Publication type:
- Article
Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2–Tie2 complex.
- Published in:
- Nature Structural & Molecular Biology, 2006, v. 13, n. 6, p. 524, doi. 10.1038/nsmb1101
- By:
- Publication type:
- Article
A phenylalanine zipper mediates APS dimerization.
- Published in:
- Nature Structural & Molecular Biology, 2004, v. 11, n. 10, p. 968, doi. 10.1038/nsmb829
- By:
- Publication type:
- Article
Turning on FLT3.
- Published in:
- Nature Structural & Molecular Biology, 2004, v. 11, n. 3, p. 212, doi. 10.1038/nsmb0304-212
- By:
- Publication type:
- Article
Cabozantinib improves mRCC outcomes regardless of PD-L1 status.
- Published in:
- Urology Times, 2019, v. 47, n. 4, p. 10
- By:
- Publication type:
- Article
RET signaling proves critical for spermatogenesis.
- Published in:
- Urology Times, 2004, v. 32, n. 4, p. 20
- By:
- Publication type:
- Article
Tyrosine kinase domain mutations in chronic myelogenous leukemia patients: A single center experience.
- Published in:
- Journal of Postgraduate Medicine, 2022, v. 68, n. 2, p. 93, doi. 10.4103/jpgm.JPGM_781_20
- By:
- Publication type:
- Article
Tyrosine kinase domain mutations in chronic myelogenous leukemia patients: Indian perspective.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Acute myeloid leukemia with 3q26 abnormality: An editorial perspective.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Regulation of actions and habits by ventral hippocampal trkB and adolescent corticosteroid exposure.
- Published in:
- PLoS Biology, 2017, v. 15, n. 11, p. 1, doi. 10.1371/journal.pbio.2003000
- By:
- Publication type:
- Article
Rictor positively regulates B cell receptor signaling by modulating actin reorganization via ezrin.
- Published in:
- PLoS Biology, 2017, v. 15, n. 8, p. 1, doi. 10.1371/journal.pbio.2001750
- By:
- Publication type:
- Article
Extracellular phosphorylation of a receptor tyrosine kinase controls synaptic localization of NMDA receptors and regulates pathological pain.
- Published in:
- PLoS Biology, 2017, v. 15, n. 7, p. 1, doi. 10.1371/journal.pbio.2002457
- By:
- Publication type:
- Article
Comparison of multiplex ligation dependent probe amplification to immunohistochemistry for assessing HER-2/ neu amplification in invasive breast cancer.
- Published in:
- Biotechnic & Histochemistry, 2006, v. 81, n. 2/3, p. 79, doi. 10.1080/10520290600822198
- By:
- Publication type:
- Article
Soluble Flt-1 as a diagnostic marker of pre-eclampsia.
- Published in:
- Australian & New Zealand Journal of Obstetrics & Gynaecology, 2008, v. 48, n. 1, p. 64, doi. 10.1111/j.1479-828X.2007.00804.x
- By:
- Publication type:
- Article
Met interacts with EGFR and Ron in canine osteosarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2013, v. 11, n. 2, p. 124, doi. 10.1111/j.1476-5829.2011.00309.x
- By:
- Publication type:
- Article
Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study
- Published in:
- Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 184, doi. 10.1111/j.1476-5829.2011.00265.x
- By:
- Publication type:
- Article
Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas.
- Published in:
- Veterinary & Comparative Oncology, 2011, v. 9, n. 3, p. 219, doi. 10.1111/j.1476-5829.2010.00253.x
- By:
- Publication type:
- Article
Epidermal growth factor enhances the malignant phenotype in canine mammary carcinoma cell lines.
- Published in:
- Veterinary & Comparative Oncology, 2011, v. 9, n. 3, p. 196, doi. 10.1111/j.1476-5829.2010.00248.x
- By:
- Publication type:
- Article
Epidermal growth factor receptor as a therapeutic target in veterinary oncology.
- Published in:
- Veterinary & Comparative Oncology, 2011, v. 9, n. 2, p. 81, doi. 10.1111/j.1476-5829.2010.00237.x
- By:
- Publication type:
- Article
Calcitriol (1,25-dihydroxycholecalciferol) enhances mast cell tumour chemotherapy and receptor tyrosine kinase inhibitor activity in vitro and has single-agent activity against spontaneously occurring canine mast cell tumours.
- Published in:
- Veterinary & Comparative Oncology, 2010, v. 8, n. 3, p. 209, doi. 10.1111/j.1476-5829.2010.00223.x
- By:
- Publication type:
- Article
A novel small molecule Met inhibitor, PF2362376, exhibits biological activity against osteosarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2007, v. 5, n. 3, p. 177, doi. 10.1111/j.1476-5829.2007.00137.x
- By:
- Publication type:
- Article
Expression of receptor tyrosine kinases VEGFR-1 (FLT-1), VEGFR-2 (KDR), EGFR-1, PDGFRa and c-Met in canine primary brain tumours.
- Published in:
- Veterinary & Comparative Oncology, 2006, v. 4, n. 3, p. 132, doi. 10.1111/j.1476-5829.2006.00101.x
- By:
- Publication type:
- Article
RT-PCR based Tyrosine Kinase Display Profiling of Canine Melanoma: IGF-1 Receptor as a Potential Therapeutic Target.
- Published in:
- Veterinary & Comparative Oncology, 2005, v. 3, n. 1, p. 57, doi. 10.1111/j.1476-5810.2005.064am.x
- By:
- Publication type:
- Article
Immunohistochemical Differentiation and Clinicopathological Features of Canine Gastrointestinal Stromal Tumors and Leiomyosarcomas.
- Published in:
- Veterinary & Comparative Oncology, 2005, v. 3, n. 1, p. 34, doi. 10.1111/j.1476-5810.2005.0064e.x
- By:
- Publication type:
- Article
Hydrogen peroxide inhibits activity of the IGF-1 receptor kinase.
- Published in:
- Redox Report, 2006, v. 11, n. 3, p. 105, doi. 10.1179/135100006X116574
- By:
- Publication type:
- Article
Aptamer‐Modified Nanohydrogel Microarrays for Bioselective Cancer Cell Immobilization.
- Published in:
- Advanced Functional Materials, 2022, v. 32, n. 45, p. 1, doi. 10.1002/adfm.202207270
- By:
- Publication type:
- Article